$4.88
+0.27 (+5.86%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+67.2% upside
Low Target
$5.68
Average Target
$8.16
High Target
$10.96
Current Price
$4.88
Current
$4.88
$4.88
Target
$8.16
$8.16
$5.68
$8.16 avg
$10.96
Scenario Analysis
Bear Case
$5.68
16.4%
Low target
Base Case
$8.16
+67.2%
Avg target
Bull Case
$10.96
+124.6%
High target
Risk/Reward
7.6x
Highly favorable
Price in Context
52-Week High
$13.67
-64.3% from high
52-Week Low
$4.50
+8.6% from low
Target vs 52W High
$8.16
-40.3% vs high
Next Earnings Report
Nov 18, 2026
9d
until earnings
EPS Est: $-0.70
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 32% | $149.45 | -41.2% |
| REGN | Buy | 36 | 72% | $76.80 | -91.5% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -40.7% |